Pharmablock Sciences delists Yaoshi convertible bonds after full redemption
Pharmablock Sciences (Nanjing) announced the full redemption of its "Yaoshi Convertible Bonds" (bond code: 123145) on September 18, 2025, leading to their delisting from the Shenzhen Stock Exchange on September 26, 2025. The redemption was triggered by a conditional redemption clause, as the bond's closing price met the criteria for 15 trading days between July 25 and August 14, 2025. The redemption price was set at 100.62 yuan per bond, including accrued interest.
As of the redemption registration date on September 17, 2025, a total of 17,486 bonds remained untransferred, resulting in a total redemption payment of 1,759,441.32 yuan. The company's stock capital has increased by 34,149,245 shares due to prior bond conversions. Trading of the bonds ceased on September 15, 2025, and the conversion to shares halted on September 18, 2025.
The full redemption means that "Yaoshi Convertible Bonds" will no longer be circulated or traded. The company confirmed the redemption has no significant impact on its financial situation, operating results, or cash flow.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Pharmablock Sciences (Nanjing) publishes news
Free account required • Unsubscribe anytime